Australia's largest stock trading and investment forum Australia's #1 stock forum

RTR

2.27%

4.5¢ rumble resources limited

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-8

First 8 Last

Share
Profile

Follow
emusan

834 Posts.

99

01/05/24

17:25

Post #: 73614150
Share

Originally posted by fourdollars ↑

So, do you hold in the hope that positive Earaheedy beneficiation results are released prior to the capital raise in the hope that the raise will be done at a higher price, or do you sell knowing that if the beneficiation results aren't published first, or if they are poor, RTR will either go bust or be raising at a fraction of the current price?

How lucky does one feel?

To feature years-old drilling results at one resource, and those of a resource "held for sale", prior to any mention of the metallurgical studies in the quarterly doesn't bode well.

Judging by the share price, no one thinks the Earaheedy resource is economic if beneficiation is impossible. So why does it take months to understand the chemical properties of the samples? At this stage, its the making or breaking of the company. There shouldn't be anything else on the agenda until this is resolved.

Expand

ask Wilson's stockbrokers they pumped it up with their research department then did the capital raise doesn't that seem a bit on the nose to you?

RTR Price at posting: 6.2¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 15 more messages in this thread...

First 8 Last

Add RTR (ASX) to my watchlist

(20min delay)
Last 4.5¢		Change 0.001(2.27%)		Mkt cap ! $34.03M

Open	High	Low	Value	Volume
4.6¢	4.7¢	4.5¢	$3.499K	76.90K

Buyers (Bids)

No.	Vol.	Price($)
2	29000	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	268145	2

View Market Depth

No.	Vol.	Price($)
2	29000	0.045
1	2275	0.044
4	395976	0.043
1	60000	0.042
2	223000	0.041

Price($)	Vol.	No.
0.047	268145	2
0.048	230000	1
0.049	335000	4
0.050	500000	1
0.051	353904	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

RTR (ASX) Chart

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-8

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-8

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News